Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Melatonin and circadian rhythm].

B Claustrat1, J Brun, F Borson-Chazot

  • 1Service de Radiopharmacie et Radioanalyse, Centre de Médecine Nucléaire, Hôpital Neuro-Cardiologique, B.P. Lyon Montchat, 69394 Lyon, France.

Revue Neurologique
|April 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Synthesis and algorithms.

Annales d'endocrinologie·2022
Same author

SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Recommendations in thyroid cytology: from technique to interpretation.

Annales d'endocrinologie·2022
Same author

[Therapeutic approaches for sleep and rhythms disorders in children with ASD].

L'Encephale·2022
Same author

Preoperative Role of RAS or BRAF K601E in the Guidance of Surgery for Indeterminate Thyroid Nodules.

World journal of surgery·2020
Same author

EXPRESSION OF MENIN IN THE HUMAN THYROID GLAND.

Acta endocrinologica (Bucharest, Romania : 2005)·2019
Same author

French Endocrine Society Guidance on endocrine side effects of immunotherapy.

Endocrine-related cancer·2018
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
See all related articles

Melatonin, a hormone produced by the pineal gland, regulates biological rhythms like sleep and temperature. Exogenous melatonin can help treat circadian rhythm disorders.

Area of Science:

  • Endocrinology
  • Neuroscience
  • Chronobiology

Context:

  • Melatonin is an indole hormone secreted by the pineal gland, primarily during nighttime.
  • Its production is regulated by the suprachiasmatic nuclei in response to the day/night cycle.
  • Light exposure significantly influences melatonin synthesis, either suppressing or entraining its production.

Purpose:

  • To describe the role of melatonin in regulating biological rhythms.
  • To explain the mechanisms controlling melatonin secretion.
  • To highlight the therapeutic potential of exogenous melatonin for circadian rhythm disorders.

Summary:

  • Melatonin acts as the internal clock's "hand," synchronizing physiological cycles such as temperature and sleep-wake patterns.
  • The hormone's secretion is controlled by the central nervous and sympathetic nervous systems.

Related Experiment Videos

  • Exogenous melatonin administration can modulate endogenous melatonin secretion, offering a basis for treating conditions like jet lag and insomnia.

    • Impact:

    • Understanding melatonin's function is crucial for managing sleep disorders and circadian rhythm disruptions.
    • This research supports the use of melatonin as a therapeutic agent for various rhythm-related conditions.
    • Further research into melatonin's phase-response curve can optimize treatment strategies for shift workers and blind individuals.